By vgreene, 23 December, 2014 Presenting w/ OAB s/sx (urgency, frequency, nocturia, urge-incontinence)
By vgreene, 23 December, 2014 2nd-line options<sup>4</sup> w/ active management of ADEs<sup>2,4,5,6,7</sup>
By vgreene, 23 December, 2014 If refractory to behavioral and drug tx:<sup>2</sup> eval by specialist if additional tx desired [EO]. Consider UCx, PVR, bladder diary/sx questionnaire, etc.
By vgreene, 23 December, 2014 If inadequate sx control<sup>2</sup> and/or unacceptable ADE w/ 1 antimuscarinic:<sup>5,6</sup> manage constipation/dry mouth,<sup>4</sup> modify dose, or try a different antimuscarinic or a β3-adrenoceptor agonist (mirabegron). [CP]
By vgreene, 23 December, 2014 Offer oral antimuscarinics<sup>5,8</sup> or β3-adrenoceptor agonists (mirabegron) [S/B]. Transdermal oxybutynin patch/gel OTC<sup>8</sup> may be offered. [R/C]
By vgreene, 23 December, 2014 Consider 1st-line options<sup>2</sup> after pt education, risk/benefit counseling [CP]
By vgreene, 23 December, 2014 Behavior tx<sup>3</sup> is 1st-line for OAB: [S/B] bladder training/delayed voiding, bladder control strategies, PFMT, fluid mgmt, diet changes, wt loss, etc. May combine w/ drug tx<sup>2</sup> [C] if behavioral tx partially effective.
By vgreene, 23 December, 2014 Assess w/ hx,<sup>1</sup> exam, UA w/micro to exclude other disorders [CP]
By vgreene, 23 December, 2014 Not recommended for initial w/u in uncomplicated pts: urodynamics, cystoscopy, renal/bladder US. [CP]